BioCentury | Sep 13, 2007
Top Story

Vital Therapies raises $28.1 million

...Ventures; HBM BioMed China; and DFJ DragonFund China joined existing investors MedVenture Associates; Valley Ventures; Toucan Capital...
BioCentury | Jun 14, 2004
Financial News

Cellular Genomics raises additional $12.6M

...In January, company raised $22.3 million. New investors included CDP Capital; RiverVest Venture Partners; and Toucan Capital...
BioCentury | Jun 14, 2004
Politics, Policy & Law

Moonlighting at NIH

...$426,400 Suntory; Novartis Director Mahendra Rao NIA - Section Chief, Stem Cells $12,450 + stock Toucan Capital...
BioCentury | Aug 17, 2001
Financial News

Layton raises $8 million

...through which it hopes to raise up to $40 million by year end. Investors included Toucan Capital...
Items per page:
1 - 4 of 4
BioCentury | Sep 13, 2007
Top Story

Vital Therapies raises $28.1 million

...Ventures; HBM BioMed China; and DFJ DragonFund China joined existing investors MedVenture Associates; Valley Ventures; Toucan Capital...
BioCentury | Jun 14, 2004
Financial News

Cellular Genomics raises additional $12.6M

...In January, company raised $22.3 million. New investors included CDP Capital; RiverVest Venture Partners; and Toucan Capital...
BioCentury | Jun 14, 2004
Politics, Policy & Law

Moonlighting at NIH

...$426,400 Suntory; Novartis Director Mahendra Rao NIA - Section Chief, Stem Cells $12,450 + stock Toucan Capital...
BioCentury | Aug 17, 2001
Financial News

Layton raises $8 million

...through which it hopes to raise up to $40 million by year end. Investors included Toucan Capital...
Items per page:
1 - 4 of 4